This Week's Poll

At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you

Supported by Medilink UK

NHS procurement a hindrance - Tony Davis of - Medilink WM - 6:49:48am Feb-15th

Would others agree that The NHS procurement organisation rules, regulations and general bureaucracy are a hindrance to the UK industry base which is 98% SME and unable to invest the amount of time and energy required to comply.

Agree/Disagree + add comment
Thumbs Up1 person agrees with this

Katy Draper of - Maketing Medicine - 18:24:57pm Apr-17th

I would agree with Tony Davis. Procurement is overly complex, time consuming and bureaucratic. Succesful companies must be good at constructing tenders in addition to actually developing and producing excellent products. Consequently products making it to market are those which have performed well in the tender exercise and are not necessarily those which are the best. However, in balance, the NHS needs to ensure that it is working with robust, safe and reliable businesses so measures to evaluate this are required. Perhaps a good place would be some compromise and understanding on both sides - i.e. industry improving tendering skills and the public sector being more open to reducing the red tape.

 
 
t